MoneyWorks4Me

RPG Life Sciences - Quaterly Results

28 Apr 2025 Evaluate
The company witnessed a 12.68% growth in the revenue at Rs. 1430.90 millions for the quarter ended March 2025 as compared to Rs. 1269.90 millions during the year-ago period.The Net Profit of the company vaulted to 786.33% to Rs. 1173.50  millions from Rs. 132.40 millions in the previous quarter.Operating profit for the quarter ended March 2025 rose to 305.50 millions as compared to 223.70 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1430.90 1269.90 12.68 6534.30 5820.50 12.26 6534.30 5820.50 12.26
Other Income 50.60 16.50 206.67 126.80 72.10 75.87 126.80 72.10 75.87
PBIDT 305.50 223.70 36.57 1723.30 1353.60 27.31 1723.30 1353.60 27.31
Interest 1.80 1.40 28.57 6.20 4.50 37.78 6.20 4.50 37.78
PBDT 1402.70 222.30 530.99 2543.10 1349.10 88.50 2543.10 1349.10 88.50
Depreciation 53.70 44.90 19.60 214.30 170.70 25.54 214.30 170.70 25.54
PBT 1349.00 177.40 660.43 2328.80 1178.40 97.62 2328.80 1178.40 97.62
TAX 175.50 45.00 290.00 496.40 301.80 64.48 496.40 301.80 64.48
Deferred Tax 0.70 -9.50 -107.37 -0.50 -23.60 -97.88 -0.50 -23.60 -97.88
PAT 1173.50 132.40 786.33 1832.40 876.60 109.03 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 21.35 17.62 21.20 26.37 23.26 13.40 26.37 23.26 13.40
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..